Skip to main content

Advertisement

Log in

Multiple functions of p21 in cancer radiotherapy

  • Review – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Greater than half of cancer patients experience radiation therapy, for both radical and palliative objectives. It is well known that researches on radiation response mechanisms are conducive to improve the efficacy of cancer radiotherapy. p21 was initially identified as a widespread inhibitor of cyclin-dependent kinases, transcriptionally modulated by p53 and a marker of cellular senescence. It was once considered that p21 acts as a tumour suppressor mainly to restrain cell cycle progression, thereby resulting in growth suppression. With the deepening researches on p21, p21 has been found to regulate radiation responses via participating in multiple cellular processes, including cell cycle arrest, apoptosis, DNA repair, senescence and autophagy. Hence, a comprehensive summary of the p21’s functions in radiation response will provide a new perspective for radiotherapy against cancer.

Methods

We summarize the recent pertinent literature from various electronic databases, including PubMed and analyzed several datasets from Gene Expression Omnibus database. This review discusses how p21 influences the effect of cancer radiotherapy via involving in multiple signaling pathways and expounds the feasibility, barrier and risks of using p21 as a biomarker as well as a therapeutic target of radiotherapy.

Conclusion

p21’s complicated and important functions in cancer radiotherapy make it a promising therapeutic target. Besides, more thorough insights of p21 are needed to make it a safe therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Funding

This work was jointly supported by the National Key Research Program of China (Grant nos. 2018YFC0115700, 2018YFC0115702), the National Natural Science Foundation of China (Grant nos. 11875299, U1532264), the Key Deployment Project of Chinese Academy of Sciences (Grant No. KFZD-SW-222) and the National Natural Science Foundation of Chinese Academy of Engineering Physics (Grant no. U1730133).

Author information

Authors and Affiliations

Authors

Contributions

YK had the idea for the review and performed the writing of the full text. JK, HL, BL, XZ and LL participated in the collection of literature. XJ and QL critically revised the work. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xiaodong Jin or Qiang Li.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Consent for publication

All authors agree with its publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuang, Y., Kang, J., Li, H. et al. Multiple functions of p21 in cancer radiotherapy. J Cancer Res Clin Oncol 147, 987–1006 (2021). https://doi.org/10.1007/s00432-021-03529-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-021-03529-2

Keywords

Navigation